GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SS Innovations International Inc (OTCPK:SSII) » Definitions » Equity-to-Asset

SS Innovations International (SS Innovations International) Equity-to-Asset : 0.44 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is SS Innovations International Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SS Innovations International's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $13.54 Mil. SS Innovations International's Total Assets for the quarter that ended in Mar. 2024 was $31.05 Mil. Therefore, SS Innovations International's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.44.

The historical rank and industry rank for SS Innovations International's Equity-to-Asset or its related term are showing as below:

SSII' s Equity-to-Asset Range Over the Past 10 Years
Min: -25.4   Med: -1.22   Max: 0.77
Current: 0.44

During the past 8 years, the highest Equity to Asset Ratio of SS Innovations International was 0.77. The lowest was -25.40. And the median was -1.22.

SSII's Equity-to-Asset is ranked worse than
74.43% of 872 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs SSII: 0.44

SS Innovations International Equity-to-Asset Historical Data

The historical data trend for SS Innovations International's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SS Innovations International Equity-to-Asset Chart

SS Innovations International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial -7.99 -2.73 0.33 -0.28 0.56

SS Innovations International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.09 0.66 0.56 0.44

Competitive Comparison of SS Innovations International's Equity-to-Asset

For the Medical Devices subindustry, SS Innovations International's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SS Innovations International's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where SS Innovations International's Equity-to-Asset falls into.



SS Innovations International Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

SS Innovations International's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=14.298/25.479
=0.56

SS Innovations International's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=13.536/31.045
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SS Innovations International  (OTCPK:SSII) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


SS Innovations International Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of SS Innovations International's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


SS Innovations International (SS Innovations International) Business Description

Traded in Other Exchanges
N/A
Address
1500 SE 15th Street, Suite 512, Fort Lauderdale, FL, USA, 33316
SS Innovations International Inc, formerly Avra Medical Robotics Inc develops medical-surgical devices. It invests in four areas including surgical robotic systems, surgical tools, implantable devices, and surgical robotic training. It is a medical robotics company developing a fully autonomous medical robotic system using proprietary software which integrates Artificial Intelligence and Deep Learning, or machine learning. By using an AI and DL-enhanced software program, the company is creating an intelligent robotic system that it believes can robotize a wide range of medical procedures currently being performed by human hands.
Executives
Barry F Cohen director, officer: COO 1600 SOUTHEAST 15TH STREET, APT 512, FORT LAUDERDALE FL 33316
Sudhir Srivastava director, 10 percent owner, officer: Chairman and CEO C/O AVRA SURGICAL ROBOTICS, ONE LIBERTY PLAZA, 35TH FLOOR, NEW YORK NY 10006
Kumar Sethi Anup officer: Chief Financial Officer C-102, DREAM APARTMENTS,, PLOT-14, SECTOR 22, DWARKA, NEW DEHLI K7 110077
Pascual Srivastava Vishwajyoti officer: President 28 HAARBAA, TRIAVENI GARDENS COMPLEX, GADAIPUR MEHRA, NEW DEHLI K7 110030
Sampige Prasannakumar Somashekar director APT 9J, NEST NO 8, 303 LG HALFI, RMV II, BANGALORE K7 560094
Annadurai Mylswamy director #344, NTI LAYOUT, 10TH MAIN, VIDHYARANYAPURA, BANGALORE K7 560067